Amyloid fibril formation by macrophage migration inhibitory factor.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Biochemical and Biophysical Research Communications - BBRC

• Publication date

  2005-12-16

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.BBRC.2005.10.040PMID 16286092
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Glutamine synthetase

  2007cited by this paper
• Re-examining the oligomerization state of macrophage migration inhibitory factor (MIF) in solution.

  2004cited by this paper
• Purification

  2004cited by this paper
• Protein folding and misfolding

  2003cited by this paper
• Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution

  2003cited by this paper
• The p53-dependent effects of macrophage migration inhibitory factor revealed by gene targeting

  2003cited by this paper
• Protein aggregation and amyloid fibril formation by an SH3 domain probed by limited proteolysis.

  2003cited by this paper
• Amyloid Precursor Protein

  2002cited by this paper
• Conformational Abs recognizing a generic amyloid fibril epitope

  2002cited by this paper
• Borna disease virus‐induced accumulation of macrophage migration inhibitory factor in rat brain astrocytes is associated with inhibition of macrophage infiltration

  2002cited by this paper
• Detection of two partially structured species in the folding process of the amyloidogenic protein beta 2-microglobulin.

  2001cited by this paper
• Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: Regulatory role in the innate immune response

  2001cited by this paper
• Amyloid fibrillogenesis: themes and variations.

  2000cited by this paper
• Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1

  2000cited by this paper
• The proinflammatory mediator macrophage migration inhibitory factor induces glucose catabolism in muscle.

  2000cited by this paper
• Glutamine synthetase, hemoglobin alpha-chain, and macrophage migration inhibitory factor binding to amyloid beta-protein: their identification in rat brain by a novel affinity chromatography and in Alzheimer's disease brain by immunoprecipitation.

  2000cited by this paper
• Targeted Disruption of Migration Inhibitory Factor Gene Reveals Its Critical Role in Sepsis

  1999cited by this paper
• Staining methods for identification of amyloid in tissue.

  1999cited by this paper
• Equilibrium and transient intermediates in folding of human macrophage migration inhibitory factor.

  1999influential reference
• The most pathogenic transthyretin variant, L55P, forms amyloid fibrils under acidic conditions and protofilaments under physiological conditions.

  1999cited by this paper
• Enzyme Activity of Macrophage Migration Inhibitory Factor toward Oxidized Catecholamines*

  1999cited by this paper
• A Proinflammatory Cytokine Inhibits P53 Tumor Suppressor Activity

  1999cited by this paper
• Sustained Mitogen-activated Protein Kinase (MAPK) and Cytoplasmic Phospholipase A2 Activation by Macrophage Migration Inhibitory Factor (MIF)

  1999cited by this paper
• Crystal structure of macrophage migration inhibitory factor complexed with (E)-2-fluoro-p-hydroxycinnamate at 1.8 A resolution: implications for enzymatic catalysis and inhibition.

  1999cited by this paper
• The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways.

  1998cited by this paper
• MIF Expression in the Rat Brain: Implications for Neuronal Function

  1998cited by this paper
• Cross‐linking and mutational analysis of the oligomerization state of the cytokine macrophage migration inhibitory factor (MIF)

  1998cited by this paper
• Macrophage Migration Inhibitory Factor Interactions with Glutathione and S-Hexylglutathione*

  1998cited by this paper
• Role of macrophage migration inhibitory factor in the regulation of the immune response.

  1997cited by this paper
• Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis

  1997cited by this paper
• Common core structure of amyloid fibrils by synchrotron X-ray diffraction.

  1997cited by this paper
• Amyloid precursor protein, Aβ and amyloid-associated proteins involved in chloroquine retinopathy in rats – immunopathological studies

  1997cited by this paper
• Alternative conformations of amyloidogenic proteins govern their behavior.

  1996cited by this paper
• The subunit structure of human macrophage migration inhibitory factor: evidence for a trimer.

  1996cited by this paper
• Crystal structure of the macrophage migration inhibitory factor from rat liver

  1996cited by this paper
• Crystal structure at 2.6-A resolution of human macrophage migration inhibitory factor.

  1996cited by this paper
• The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid.

  1996cited by this paper
• Local and distant histopathological effects of unilateral amyloid-beta 25-35 injections into the amygdala of young F344 rats.

  1996cited by this paper
• The structure and physicochemical properties of rat liver macrophage migration inhibitory factor.

  1995cited by this paper
• MIF as a glucocorticoid-induced modulator of cytokine production

  1995cited by this paper
• Crystallization of rat liver macrophage migration inhibitory factor for MAD analysis.

  1995cited by this paper
• Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF).

  1994cited by this paper
• Boundary analysis in sedimentation velocity experiments.

  1994cited by this paper
• Purification and characterization of human macrophage migration inhibitory factor: evidence for specific binding to glutathione and formation of subunit structure.

  1993cited by this paper
• Biochemical and Biophysical Research Communications

  1960cited by this paper

• Cross-talk between adipose tissue and microbiota-gut-brain-axis in brain development and neurological disorder.

  2024cites this paper
• MIF contribution to progressive brain diseases

  2024cites this paper
• Multifaceted interconnections between macrophage migration inhibitory factor and psychiatric disorders.

  2021cites this paper
• Adipose-Derived Molecules–Untouched Horizons in Alzheimer’s Disease Biology

  2020cites this paper
• Upregulation of MIF as a defense mechanism and a biomarker of Alzheimer’s disease

  2019cites this paper
• Graphene quantum dots rescue protein dysregulation of pancreatic β-cells exposed to human islet amyloid polypeptide

  2019cites this paper
• Macrophage migration inhibitory factor: A multifaceted cytokine implicated in multiple neurological diseases

  2017cites this paper
• Probing amyloid‐β pathology in transgenic Alzheimer's disease (tgArcSwe) mice using MALDI imaging mass spectrometry

  2016cites this paper
• MIF, a controversial cytokine: a review of structural features, challenges, and opportunities for drug development

  2016cites this paper
• The Role of Inflammatory Mediators in the Pathogenesis of Alzheimer's Disease.

  2015cites this paper
• Regulation of macrophage migration inhibitory factor expression and its role in stroke and Alzheimer’s disease.

  2015cites this paper
• Aβ, tau, α-synuclein, huntingtin, TDP-43, PrP and AA are members of the innate immune system: a unifying hypothesis on the etiology of AD, PD, HD, ALS, CJD and RSA as innate immunity disorders

  2013cites this paper
• Hunting the Chameleon: Structural Conformations of the Intrinsically Disordered Protein Alpha‐Synuclein

  2012cites this paper
• Formation of Amyloid-Like Fibrils by Y-Box Binding Protein 1 (YB-1) Is Mediated by Its Cold Shock Domain and Modulated by Disordered Terminal Domains

  2012cites this paper
• The Role of Macrophage Migration Inhibitory Factor in Alzheimer’s Disease

  2010cites this paper
• immunoactive carboxyl-terminal peptide TKKQKTDEDD timulates lymphocyte reactions , induces dendritic cell maturation and dopts a-sheet conformation in a sequence-specific manner

  2009cites this paper
• Prothymosin alpha immunoactive carboxyl-terminal peptide TKKQKTDEDD stimulates lymphocyte reactions, induces dendritic cell maturation and adopts a beta-sheet conformation in a sequence-specific manner.

  2009cites this paper
• The conformational flexibility of the carboxy terminal residues 105-114 is a key modulator of the catalytic activity and stability of macrophage migration inhibitory factor.

  2008cites this paper
• Expression of CD74 is increased in neurofibrillary tangles in Alzheimer's disease

  2008cites this paper
• Oxidative metabolism of dopamine: a colour reaction from human midbrain analysed by mass spectrometry.

  2008cites this paper